Construction of a Prognostic Nomogram Model for Patients with Mucinous Breast Cancer.

OBJECTIVE

The objective of the study is to develop a nomogram for estimating three- and five-year survival rates in mucinous breast cancer patients.

METHODS

Between 2010 and 2016, the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) were searched as a data source for patients associated with mucinous breast cancer (MBC). A total of 3964 patients were recruited after screening. The multivariate Cox model and the univariate Kaplan-Meier (KM) approach were employed to evaluate the independent prognostic markers, followed by developing a nomogram for estimating three- and five-year survival rates in MBC patients. Consequently, the consistency index (C-index) was employed to assess the predictive accuracy of the generated nomogram.

RESULTS

Age, race, T stage, M stage, surgery, and radiotherapy were all independent predictive biomarkers for the MBC patients ( < 0.05). The nomogram was finally developed based on the underlined factors. Furthermore, the C-index of 0.803 and reliable calibration curves were obtained in the nomogram's assessment.

CONCLUSIONS

In patients with mucinous breast cancer, the proposed nomogram provides a viable tool for accurate prognostic prediction. In clinical practice, it could serve as a personalized diagnosis tool, estimate prognosis, and help in suggesting treatment plans for patients with MBC.